Prodesse, Inc.'s ProAdeno+ Assay Cleared for US Marketing by FDA
12/9/2010 6:51:47 AM
More...
|
FDA Clears Prodesse, Inc.'s ProFAST+ Assay to Identify Three Strains of Influenza A, Including 2009 H1N1
7/27/2010 6:43:02 AM
More...
|
Prodesse, Inc.'s ProParaflu+(TM) Assay Cleared for US Marketing by FDA
11/25/2009 7:25:04 AM
More...
|
FDA Grants Emergency Use Authorization of the Prodesse, Inc. ProFlu-ST(TM)
10/29/2009 6:23:37 AM
More...
|
Gen-Probe Incorporated (GPRO) Completes Acquisition of Prodesse, Inc., Leader in Molecular Testing for Respiratory Infectious Diseases
10/23/2009 8:20:00 AM
More...
|
Gen-Probe Incorporated (GPRO) (JOBS) to Acquire Flu Test Maker, Prodesse, Inc. for $60 Million
10/7/2009 4:52:12 AM
More...
|
Prodesse, Inc. Acquires Non-Exclusive U.S. Distribution Rights for Cepheid (CPHD) SmartCycler(R) System
9/23/2009 2:02:18 PM
More...
|
Prodesse, Inc. Receives Special 510(k) for ProFlu+(TM) Assay Test Correctly Identifies 2009 H1N1 Influenza Virus as Influenza A
8/24/2009 11:14:41 AM
More...
|
Prodesse, Inc. Announces Licensure of Two Additional Patents
7/1/2009 10:43:16 AM
More...
|
Kevin T. Conroy, Former Third Wave Technologies, Inc. (TWTI) CEO, Joins Prodesse, Inc. Board
5/13/2009 12:54:11 PM
More...
|
|